Jeffery D. Zwicker

university of montana system

H指数:4

被引数:59

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DCC-3084, a RAF dimer inhibitor, broadly inhibits BRAF class I, II, III, BRAF fusions, and RAS-driven solid tumors leading to tumor regression in preclinical models

CANCER RESEARCH

IF16.6

2023-04-042

PRE

Bulfer, Stacie L.; Le Bourdonnec, Bertrand; Zwicker, Jeffery D.; Ahn, Yu Mi; Al-Ani, Gada; Al-Hashimi, Hikmat; Crawley, Chase; Elliott, Kristin M.; Faisal, Saqib; Harned, Andrew M.; Heiniger, Cale L.; Hood, Molly M.; Javed, Salim; Kennedy, Michael; Large, Joshua W.; Leary, Cynthia B.; Lu, Wei-Ping; Luther, Kylie; Petty, Max D.; Picard, Hunter R.; Proto, Justin T.; Romero, Yeni K.; Stanley, Forrest A.; Stoltz, Kristen L.; Tanner, Daniel C.; Telikepalli, Hanumaiah; Timson, Mary J.; Vogeti, Lakshminarayana; Vogeti, Subha; Yang, Sihyung; Zhong, Lexy H.; Smith, Bryan D.; Flynn, Daniel L.

DP-9024, an investigational small molecule modulator of the integrated stress response kinase GCN2, synergizes with asparaginase therapy in leukemic tumors

CANCER RESEARCH

IF16.6

2023-04-040

PRE

DP-9149, an investigational small molecule modulator of the Integrated Stress Response kinase GCN2, pre-clinically causes solid tumor growth inhibition as a single agent and regression in combination with standard of care agents

CANCER RESEARCH

IF16.6

2023-04-040

PRE

DP-9024, an investigational small molecule modulator of the Integrated Stress Response kinase PERK, causes B-cell cancer growth inhibition as single agent and in combination with standard-of-care agents

CANCER RESEARCH